Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

LORAZEPAM VERSUS DIAZEPAM IN THE ACUTE TREATMENT OF EPILEPTIC SEIZURES AND STATUS EPILEPTICUS

Appletan, Richard, Sweeney, Anne, Choonara, Imti, Robson, Joan, Molyneux, Elizabeth · 1995 · Developmental Medicine & Child Neurology

Abstract

SUMMARY: Lorazepam was compared with diazepam for the treatment of acute convulsions and status epilepticus in 102 children in a prospective, open, ‘odd and even dates’ trial. Convulsions were controlled in 76 per cent of patients treated with a single dose of lorazepam and 51 per cent of patients treated with a single dose of diazepam. Significantly fewer patients treated with lorazepam required additional anticonvulsants to terminate the seizure. Respiratory depression occurred in 3 per cent of lorazepam‐treated patients and 15 per cent of diazepam‐treated patients. No patient who received lorazepam required admission to the intensive care unit for either respiratory depression or persisting status epilepticus. Rectally administered lorazepam appeared to be particularly valuable (100 per cent efficacy) when venous access was not possible. RÉSUMÉ: Lorazepam vs diazepam dans le Tretirement aigu des crises comitiales el de L'étal de mat épileptique Le lorazepam a été comparé au diazepam dans lc traitement aigu de convulsions et de L'et at de mal épileptique chcz 102 enfants, dans une étude prospective, ouverte, en essais ‘jours pairs et impairs.’ Les convulsions furent eontrolées chez 76 pour cent des patients tradés par lorazepam et 51 pour cent des patients traités par diazepam. Significativement moins de patients traités par lorazepam exigérent des anticomitiaux complémentaires pour terminer la crise. Une dépression respiratoire se manifesta chez 3 pour cent des patients traités par lorazepam et 15 pour cent des patients traités par diazepam. Aucun des patients traités par lorazepam n'exigércnt une admission dans une unité de soins intensifs pour dépression respiratoire ou persistance d'un etal de mal. Le lorazepam administré par voic rectalc semble particuliércment efficace (100 pour cent d'efficacité) lorsqul'il n'y a pas les conditions d'une injection intra‐veincusc. ZUSAMMENFASSUNG: Lorazepam versus Diazepam bei der Akutversorung von epileptischen Anjâilen mid Status epilepticus Bei 102 Kindern wurde in einer prospektiven offenen ‘odd and even dates’ Studie Lorazepam mit Diazepam bei der Behandlung von akulen Anfällen und des Status epilepticus verglichen. Bei 76 Prozent der mit Lorazepam und bei 51 Prozent der mit Diazepam bchandelten Patientcn konnten die Anfälle untcr Kontrolle gebracht werden. Von den mit Lorazepam behandelten Patienten brauchten signifikant weniger zusätzlichc Antikonvulsiva, urn die Anfälle zu stoppen. Eine Atemdepression wurde unter Lorazepam nur bei 3 Prozent unter Diazepam bei 15 Prozent der Patienten beobachtet. Kein Patient, der mit Lorazepam behandelt wurde, mußte weder wegen einer Atemdepression noch wegen eines anhaltenden Status epilepticus auf die Intensivstation aufgenommen werden. Rcktal verabreichtes Lorazepam schien besonders geeignet (100 Prozent Wirksamkeit), wenn ein venöser Zugang nicht möglich war. RESUMEN: Lorazepam versus diazepam en el tratamiento agudo de crisis epilepsias y ‘status epilepticus’ Se comparó el lorazepam con el diazepam en el tratamiento de las convulsiones agudas y del ‘status epilepticus' en 102 niños en un ensayo prospective abierto y con datos ’pares e impares‘. Las convulsiones se controlaron en el 76 por ciento de los pacientes tratados con lorazepam y en el 51 por ciento de los con diazepam. Fué significativo el que menos pacientes con lorazepam requireran anticonvulsivantcs adicionales para terminar el ataque. Una depresión respiratoria tuvo lugar en el 3 por ciento de los pacientes con lorazepam y en el 15 por cicnto de los con diazepam. Ningún paciente con lorazepam necesitó ingresar en la UCI ni por depresion respiratoria ni por persistencia del “status”. Administrado rectalmente el lorazepan mostró scr de particular valor (100 por ciento de eficacia) cuando la via venosa no era posible.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1469-8749.1995.tb15014.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 194

Metadata

Authors
Appletan, R., Sweeney, A., Choonara, I., Robson, J., & Molyneux, E.
Venue
Developmental Medicine & Child Neurology
Publisher
Wiley
Published
1995-08
Volume
37
Issue
8
Pages
682-688
ISSN
  • 0012-1622 (ISSN-L)
  • 1469-8749
OpenAlex
W2108055889
Cited by
194
References
1
FWCI
3.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LORAZEPAM VERSUS DIAZEPAM IN THE ACUTE TREATMENT OF EPILEPTIC SEIZURES AND STATUS EPILEPTICUS. https://app.cochat.ai/papers/10.1111/j.1469-8749.1995.tb15014.x
The paper
Appletan, R., Sweeney, A., Choonara, I., Robson, J., & Molyneux, E. (1995). LORAZEPAM VERSUS DIAZEPAM IN THE ACUTE TREATMENT OF EPILEPTIC SEIZURES AND STATUS EPILEPTICUS. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1995.tb15014.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.